Intravenous Iron Sucrose for Iron Deficiency Anemia

Patient Assessment and Rationale for Treatment

A 53-year-old female patient with iron deficiency anemia secondary to chronic blood loss from heavy uterine bleeding requires prompt treatment, as indicated by the American Gastroenterological Association (AGA) guidelines 1, 2
The patient's severe iron deficiency, as evidenced by low iron saturation and ferritin levels, necessitates rapid correction, which can be achieved with intravenous iron sucrose 4
Heavy menstrual bleeding is a condition where intravenous iron is appropriate without requiring prior oral iron failure, according to clinical guidelines 4, 3

The American Gastroenterological Association (AGA) 2024 guidelines recommend intravenous iron as first-line treatment in patients losing iron at a rate too rapid for oral intake to compensate for the loss 1, 2
Intravenous iron should be considered for patients with conditions where oral iron is not likely to be absorbed, as stated by the AGA guidelines 1
The patient's symptomatic presentation, including fatigue, shortness of breath, and dizziness, warrants prompt treatment with intravenous iron sucrose to rapidly increase hemoglobin levels 1, 4, 3

Iron sucrose can be administered as a 200 mg dose over 10 minutes, with multiple doses potentially required based on the severity of anemia 4, 3, 5
Resuscitation facilities should be available during administration as a precaution, and patients should be monitored for potential adverse reactions during infusion 4, 3, 6
Follow-up monitoring of hemoglobin, iron saturation, and ferritin is essential to assess response and determine if additional iron therapy is needed 4, 3